2.0
Jun 30, 2017
Anonymous employee
Former employee
Recommend
CEO approval
Business outlook
Pros
Used to be one of the best pharma companies in the US. They have great products and strong pipeline.
Cons
Consistently having restructuring and layoffs. Advair is going generic and this is really going to impact all employees. The bonus structure is subjective and reps have no control over their bonus. Management does not care about employees and try to find a way to push out seasoned reps. Limited opportunities for growth within the field. They do not respect work life balance. Senior management is horrible and don't care about the field.